• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back To Search Results
Recognition List Number: 034 FR Publication Date: 01/30/2014 

Part B: Supplementary Information

Recognition Number 4-91: ADA / ANSI Specification No.80 2001 (Reaffirmed 2013), dental materials - determination of color stability. (Dental/ENT)

Date of Standard: 2001. 
Addresses of Standards Development Organizations:
 American Dental Association (ADA)
  211 East Chicago Avenue
  Chicago, IL 60611-2678
 American National Standards Institute (ANSI)
  25 West 43rd Street
  4th Floor
  New York, NY 10036
CDRH Offices and Divisions associated with recognized standards:
Devices Affected:
Artificial teeth, porcelain teeth, artificial teeth with metal insert, crown and bridge temporary resin, tooth shade resin material, denture relining and repair resin
Processes Affected:
510(k), PMA, PDP, IDE, HDE, Quality System Regulation
Type of Standard:
 National, Vertical
Extent of Recognition:
Complete standard and any annexes.
Related CFR Citations and Product Codes:
Device Name Device
§872.3690 Material, Tooth Shade, Resin Class 2 EBF
§872.3760 Resin, Denture, Relining, Repairing, Rebasing Class 2 EBI
§872.3770 Crown And Bridge, Temporary, Resin Class 2 EBG
§872.3900 Teeth, Artificial, Posterior With Metal Insert Class 1 ELJ
§872.3910 Teeth, Artificial, Backing And Facing Class 1 ELK
§872.3920 Teeth, Porcelain Class 2 ELL
Relevant Guidance:
Guidance for Industry and FDA Staff Dental Composite Resin Devices - Premarket Notification [510(k)] Submissions Document issued on: October 26, 2005
FDA Technical Contact:
 Michael Adjodha
  10903 New Hampshire Avenue WO66 RMG308
  Silver Spring MD 20993
  email: michael.adjodha@fda.hhs.gov